Biotech · Private company · Burlington, MA, US
Makscientific, LLC
Track this companyFree. Adds Makscientific, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Dual Fatty Acid Amide Hydrolase (FAAH)/Monoacylglycerol lipase (MAGL) Inhibitors for Cannabis Use Disorder (CUD).Fiscal year 2025 · $55KNIH RePORTER 3R43DA057439-01S1 · fetched Nov 12, 2026
- A CB1 Antagonist for Treatment of Kidney DiseaseFiscal year 2024 · $572.7KNIH RePORTER 1R44DK139888-01 · fetched Nov 12, 2026